Drug Profile
Disopyramide extended release - Beijing CoSci Med Tech
Latest Information Update: 03 Aug 2016
Price :
$50
*
At a glance
- Originator Beijing CoSci Med-Tech
- Class Class Ia antiarrhythmics; Pyridines
- Mechanism of Action Cholinergic receptor antagonists; Voltage-gated sodium channel inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Ventricular arrhythmias
Most Recent Events
- 03 Aug 2016 Chemical structure information added
- 22 Jul 2016 Investigation in Ventricular arrhythmias in China (PO)